For all you sub-penny stock traders, keep an eye on Shot Spirits Corp. (Pink Sheets: SSPT). Shares were up almost 92 percent on heavy volume in morning trading on Thursday after the company announced a deal with American Express, “which further positions GuestMetrics™ IP as a compelling advantage in an industry which turns over three trillion dollars a year,” according to Shot Spirits CEO, Brian Barrett.
[–quote–]
GuestMetrics provides a “unifiedied view into the behavior of guests and the performance of your business,” according to the Company’s Web site. “GuestMetrics tools are fully and seamlessly integrated with your point-of-sale system (POS) so they can: capture table-level purchase information from the point of sale; combine guest information with detailed business operations data across multiple locations and POS systems; and create detailed reports through in-depth analysis.
According to today’s news release, GuestMetrics™ is currently in discussions with a worldwide hospitality provider with hotels, resorts and conference centers as just a handful of its brands. At the same time, Shot Spirits Corp’s Shot Spirits International is confident it will be enjoying another strong quarter in its partnership with the revolutionary, Eco-friendly Beverage Pouch Group.
“It’s simply amazing technology and extremely valuable to those in highly competitive industries such as hospitality and the prepaid (credit and debit card) industry,” said Barrett. “IP is hard to get your head around sometimes. It’s invisible; but the output is compelling to say the least. We’re thrilled that AMEX recognizes this as we feel GuestMetrics data tracking abilities will become an indispensable tool for various industries as we continue to expand our capabilities and IP applications.”

We first covered Neurocrine Biosciences, Inc. (Nasdaq: NBIX) in late May 2010, when the stock was trading at $3.40 a share. About a week after our post, shares of NBIX climbed to a high of $5.20 a share. Neurocrine rallied again on Thursday, climbing almost 8 percent to a 52-week high of $5.79 a share in morning trading after the company announced a development deal with privately held German drug maker, Boehringer Ingelheim.
Shares of memory subsystems maker Netlist, Inc. (Nasdaq: NLST) continued their rally on Monday morning, climbing about 32 percent from Friday’s close. Shares gained about 30 percent on Friday as well, after the company announced that its HyperCloud™ memory module was been selected to run on servers owned by British IT solutions provider, Viglen to support High Performance Computing (HPC) applications.
Shares of compliance and management software maker ArcSight, Inc. (Nasdaq: ARST) were up more than 24 percent in morning trading on Friday after the company announced better-than-expected fourth quarter earnings, and painted a rosier-than-expected picture for the current quarter.
Shares of alternative energy solutions provider, Carbon Sciences, Inc. were up more than 70 percent in morning trading on Tuesday.